Expression pattern analysis and characterization of the hereditary sensory and autonomic neuropathy 2 A (HSAN2A) gene with no lysine kinase (WNK1) in human dorsal root ganglion.


Journal

Experimental neurology
ISSN: 1090-2430
Titre abrégé: Exp Neurol
Pays: United States
ID NLM: 0370712

Informations de publication

Date de publication:
12 2023
Historique:
received: 22 06 2023
revised: 20 08 2023
accepted: 27 09 2023
medline: 10 11 2023
pubmed: 5 10 2023
entrez: 4 10 2023
Statut: ppublish

Résumé

Inherited painless neuropathies arise due to genetic insults that either block the normal signaling of or destroy the sensory afferent neurons in the dorsal root ganglion (DRG) responsible for transducing noxious stimuli. Complete loss of these neurons leads to profound insensitivity to all sensory modalities including pain. Hereditary sensory and autonomic neuropathy type 2 (HSNAII) is a rare genetic neuropathy characterized by a progressive distal early onset sensory loss. This syndrome is caused by autosomal recessive mutations in the with-no-lysine protein kinase 1 (WNK1) serine-threonine kinase gene. Of interest, disease-associated mutations are found in the large exon, termed "HSN2," which encodes a 498 amino acid domain C-terminal to the kinase domain. These mutations lead to truncation of the HSN2-containing proteins through the addition of an early stop codon (nonsense mutation) leading to loss of the C-terminal domains of this large protein. The present study evaluates the transcripts, gene structure, and protein structure of HSN2-containing WNK1 splice variants in DRG and spinal cord in order to establish the basal expression patterns of WNK1 and HSN2-containing WNK1 splice variants using multiplex fluorescent situ hybridization. We hypothesized that these transcripts would be enriched in pain-sensing DRG neurons, and, potentially, that enrichment in nociceptive neurons was responsible for the painless phenotypes observed. However, our in-depth analyses revealed that the HSN2-WNK1 splice variants were ubiquitously expressed but were not enriched in tachykinin 1-expressing C-fiber neurons, a class of neurons with a highly nociceptive character. We subsequently identified other subpopulations of DRG neurons with higher levels of HSN2-WNK1 expression, including mechanosensory large fibers. These data are inconsistent with the hypothesis that this transcript is enriched in nociceptive fibers, and instead suggest it may be related to general axon maintenance, or that nociceptive fibers are more sensitive to the genetic insult. These findings clarify the molecular and cellular expression pattern of this painless neuropathy gene in human tissue.

Identifiants

pubmed: 37793538
pii: S0014-4886(23)00237-6
doi: 10.1016/j.expneurol.2023.114552
pii:
doi:

Substances chimiques

Protein Serine-Threonine Kinases EC 2.7.11.1
WNK Lysine-Deficient Protein Kinase 1 EC 2.7.11.1
Minor Histocompatibility Antigens 0
Intracellular Signaling Peptides and Proteins 0
Lysine K3Z4F929H6
WNK1 protein, human EC 2.7.11.1

Types de publication

Journal Article Research Support, N.I.H., Intramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

114552

Subventions

Organisme : Intramural NIH HHS
ID : ZIA CL090034
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIA CL090035
Pays : United States
Organisme : Intramural NIH HHS
ID : ZIC NS009441
Pays : United States

Informations de copyright

Published by Elsevier Inc.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare the following financial interests/personal relationships which may be considered as potential competing interests. Disclosure statement: Andre Ghetti is an employee and shareholder of AnaBios Corporation.

Auteurs

Matthew R Sapio (MR)

Department of Perioperative Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.

Diana M King (DM)

Department of Perioperative Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.

Ellen S Staedtler (ES)

Department of Perioperative Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.

Dragan Maric (D)

National Institute of Neurological Disorders and Stroke, Flow and Imaging Cytometry Core Facility, Bethesda, MD 20892, USA.

Jahandar Jahanipour (J)

National Institute of Neurological Disorders and Stroke, Flow and Imaging Cytometry Core Facility, Bethesda, MD 20892, USA.

Natalya A Kurochkina (NA)

The School of Theoretical Modeling, Washington, DC 20006, USA.

Allison P Manalo (AP)

Department of Perioperative Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.

Andre Ghetti (A)

Anabios, Corporation, San Diego, CA 92109, USA.

Andrew J Mannes (AJ)

Department of Perioperative Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA.

Michael J Iadarola (MJ)

Department of Perioperative Medicine, Clinical Center, National Institutes of Health, Bethesda, MD 20892, USA. Electronic address: michael.iadarola@nih.gov.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH